Transarterial Chemoembolization Combined With Apatinib Plus PD-1 Inhibitors for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Multicenter Retrospective Study

医学 肝细胞癌 阿帕蒂尼 内科学 胃肠病学 放射科 门静脉 多中心研究 回顾性队列研究 肿瘤科 癌症 随机对照试验
作者
Wei-Li Xia,Xiao-Hui Zhao,Yuan Guo,Hongtao Hu,Guangshao Cao,Zhen Li,Weijun Fan,Shijun Xu,Hailiang Li
出处
期刊:Clinical and translational gastroenterology [American College of Gastroenterology]
卷期号:14 (5): e00581-e00581 被引量:2
标识
DOI:10.14309/ctg.0000000000000581
摘要

INTRODUCTION: The aim of this study was to compare transarterial chemoembolization (TACE) combined with apatinib and PD-1 inhibitors (TACE-AP) with TACE combined with apatinib alone (TACE-A) in the treatment of hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) and to explore the prognostic factors affecting the survival of patients. METHODS: This retrospective study analyzed data of patients with HCC with PVTT who were treated with TACE-AP or TACE-A between December 2018 and June 2021. The primary end points of the study were progression-free survival (PFS) and overall survival (OS), and the secondary end points were objective response rate (ORR) and adverse events (AEs). Propensity score matching (PSM) and stabilized inverse probability weighting (sIPTW) analyses were used to reduce patient selection bias, and Cox regression analysis was used to analyze prognostic factors affecting patient survival. RESULTS: Sixty-nine and 40 patients were included in the TACE-A and TACE-AP groups, respectively. After PSM and IPTW analyses, the median PFS and median OS in the TACE-AP group were significantly higher than those in the TACE-A group (PFS: after PSM, 6.9 vs 4.0 months, P < 0.001, after IPTW, 6.5 vs 5.1 months, P < 0.001; OS: after PSM, 14.6 vs 8.5 months P < 0.001, after IPTW, 16.1 vs 10.5 months, P < 0.001). After PSM and IPTW analyses, the tumor ORR in the TACE-AP group was significantly higher than that in the TACE-A group (PSM, 53.6% vs 17.9%, P = 0.005; IPTW, 52.5% vs 28.6%, P = 0.013). All treatment-related AEs were observed to be tolerated. Multivariate Cox regression analysis showed that the main prognostic factors affecting the survival of patients were tumor number, PVTT type, alpha-fetoprotein, and treatment mode. DISCUSSION: In the treatment of patients with HCC with PVTT, TACE-AP significantly improved PFS, OS, and ORR, and the AEs were safe and controllable.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
天天浇水完成签到,获得积分10
1秒前
123完成签到,获得积分10
1秒前
起名字好难起完成签到,获得积分10
2秒前
莎莎完成签到 ,获得积分10
4秒前
5秒前
5秒前
sherry221完成签到,获得积分10
6秒前
花川完成签到 ,获得积分10
6秒前
Silence完成签到,获得积分10
8秒前
jscr发布了新的文献求助10
9秒前
junxi完成签到 ,获得积分20
9秒前
黄瓜橙橙完成签到,获得积分0
11秒前
学谦完成签到,获得积分10
12秒前
13秒前
14秒前
孙非完成签到,获得积分10
14秒前
苹果萧完成签到 ,获得积分10
15秒前
活力寒梅完成签到,获得积分10
15秒前
zwj003完成签到,获得积分10
19秒前
小木子发布了新的文献求助10
19秒前
21秒前
852应助科研通管家采纳,获得10
24秒前
英姑应助科研通管家采纳,获得10
24秒前
无私如松应助科研通管家采纳,获得10
24秒前
研友_VZG7GZ应助科研通管家采纳,获得10
25秒前
打打应助科研通管家采纳,获得10
25秒前
慕青应助科研通管家采纳,获得10
25秒前
丘比特应助科研通管家采纳,获得10
25秒前
orixero应助科研通管家采纳,获得10
25秒前
科研通AI2S应助科研通管家采纳,获得10
25秒前
25秒前
25秒前
小垃圾完成签到,获得积分10
25秒前
27秒前
SI完成签到,获得积分10
29秒前
火星上惜蕊完成签到,获得积分20
32秒前
勤恳怀梦完成签到,获得积分10
32秒前
独特乘云完成签到,获得积分10
32秒前
陶醉夏旋完成签到,获得积分20
32秒前
yzy完成签到,获得积分10
33秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Defense against predation 800
Very-high-order BVD Schemes Using β-variable THINC Method 568
Chen Hansheng: China’s Last Romantic Revolutionary 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3137101
求助须知:如何正确求助?哪些是违规求助? 2788086
关于积分的说明 7784523
捐赠科研通 2444109
什么是DOI,文献DOI怎么找? 1299758
科研通“疑难数据库(出版商)”最低求助积分说明 625574
版权声明 601011